Aptose Biosciences APTO Balance Sheet

Income Statement

Quarter End	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
	CAD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	16.21M	12.68M	16.67M	19.72M	92.56M	115.2M	72.6M	39.33M
Total Current Assets	15.81M	12.42M	16.52M	17.66M	90.99M	114.14M	71.87M	37.93M
Cash and Equivalents	6.74M	11.96M	15.41M	16.58M	59.75M	87.08M	36.99M	22.76M
Total Non-Current Assets	808k	506k	300k	4.12M	618k	486k	574k	366k
Total Liabilities	1.86M	2.34M	2.21M	4.3M	5.32M	5.79M	7.32M	13.34M
Total Current Liabilities	1.86M	2.34M	2.21M	2.98M	4.43M	5.37M	7.31M	12.42M
Total Non-Current Liabilities	0	0	0	2.64M	1.79M	840k	20k	1.84M
Common Equity	230.25M	243.88M	249.46M	267.25M	366.25M	429.65M	437.41M	437.95M
Retained Earnings	-237.98M	-255.89M	-253.6M	-281.14M	-313.44M	-373.38M	-433.99M	-478.01M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	CAD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	11.61M	11.97M	16.87M	100.48M	126.26M	82.53M	51.03M	12.99M
Total Current Assets	11.33M	11.83M	16.49M	98.77M	125.08M	81.74M	49.52M	11.89M
Cash and Equivalents	10.66M	10.63M	15.3M	79.84M	117.39M	39.11M	36.97M	9.25M
Total Non-Current Assets	9.84M	10.2M	14.08M	93.93M	118.92M	74.24M	37.74M	-2.9M
Total Liabilities	1.77M	1.77M	2.79M	6.55M	7.35M	8.29M	13.29M	15.89M
Total Current Liabilities	1.77M	1.77M	2.79M	5.54M	6.81M	8.17M	12.28M	15.27M
Total Non-Current Liabilities	0	0	0	2.02M	1.07M	230k	2M	621k
Total Equity	9.84M	10.2M	14.08M	93.93M	118.92M	74.24M	37.74M	-2.9M
Common Equity	239.11M	238.38M	261.07M	365.49M	429.52M	437.39M	437.52M	444.81M
Retained Earnings	-251.54M	-246.79M	-279.95M	-301.92M	-357.15M	-422.51M	-464.33M	-515.54M